Abstract Body

Background: While the primate origins of human retroviruses have been identified by detailed epidemiologic and phylogenetic analyses of isolates from both humans and nonhuman primates (NHPs), of the seven known species of human retroviruses, one, HTLV-4, lacks a known animal reservoir. HTLV-4 was discovered in 2005 in a 48-yr-old male hunter from rural Cameroon who reported hunting monkeys, chimpanzees, gorillas, and other animals and currently represents the only known primate (human or simian) virus in this lineage. Methodology: 1,107 individual captive and wild NHPs from Cameroon consisting of 21 species were screened for evidence of simian T-cell lymphotropic virus type 4 (STLV-4) infection, the simian origin of HTLV-4, using a real-time PCR assay specific for the detection of HTLV-4-like pol sequences. pol, env, tax and full genome sequences were obtained by nested PCR from positive samples. Phylogenetic analyses to demonstrate the genetic relatedness of STLV-4 and HTLV-4 and to estimate the possible date of STLV-4 entry into humans using detailed Bayesian phylogenetic analyses were performed. Results: Of the 1,107 individuals of 21 species tested, samples from only three wild and three captive gorillas were positive. Partial PTLV-4 (primate-T-cell lymphotropic virus type 4) pol, env and tax sequences were detected for the six gorilla samples and all showed at least 99% nucleotide identity to HTLV-4(1863LE) and to each other. These results were confirmed by phylogenetic analysis of tax and pol sequences which showed a clustering of all STLV-4 sequences with those from HTLV-4. One gorilla was dually infected with PTLV-1. TMRCA estimates for the PTLV-4 ancestor were 3,300 – 8,400 years suggesting a relatively recent introduction of STLV-4 into humans. Conclusions: These findings indicate that STLV-4 is endemic to gorillas, and that HTLV-4 recently emerged from a gorilla reservoir, likely through the hunting and butchering of wild gorillas. Our findings shed further light on the importance of gorillas as keystone reservoirs for the evolution and emergence of human infectious diseases and provide a clear course for preventing HTLV-4 emergence through management of contact with gorillas, the development of improved assays for HTLV-4/STLV-4 detection, and the monitoring of STLV-4 among gorillas and for HTLV-4 zoonosis among individuals exposed to gorilla populations.